Patienterne i RA forsøg I, II og III blev testet på forskellige tidspunkter for anti- adalimumab antistoffer mod adalimumab fra 6. til 12. måned.
Patients in RA Studies I, II and III were tested at multiple timepoints for anti-adalimumab antibodies during the 6 to 12 month period.